Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of 4D Molecular Therapeutics Inc (NASDAQ: FDMT) was $4.5 for the day, up 2.04% from the previous closing price of $4.41. In other words, the price has increased by $2.04 from its previous closing price. On the day, 1.49 million shares were traded. FDMT stock price reached its highest trading level at $4.61 during the session, while it also had its lowest trading level at $4.3.
Ratios:
Our analysis of FDMT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.36 and its Current Ratio is at 12.36. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BMO Capital Markets on January 13, 2025, Downgraded its rating to Market Perform and sets its target price to $15 from $40 previously.
On November 21, 2024, Morgan Stanley started tracking the stock assigning a Underweight rating and target price of $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 16 ’24 when Bizily Scott sold 500 shares for $16.33 per share. The transaction valued at 8,165 led to the insider holds 6,781 shares of the business.
Bizily Scott sold 500 shares of FDMT for $7,500 on Aug 19 ’24. The Chief Legal Officer now owns 6,781 shares after completing the transaction at $15.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FDMT now has a Market Capitalization of 208460704 and an Enterprise Value of -89123112. For the stock, the TTM Price-to-Sale (P/S) ratio is 10422.96 while its Price-to-Book (P/B) ratio in mrq is 0.44. Its current Enterprise Value per Revenue stands at -3874.918 whereas that against EBITDA is 0.448.
Stock Price History:
The Beta on a monthly basis for FDMT is 2.82, which has changed by -0.7203232 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, FDMT has reached a high of $18.14, while it has fallen to a 52-week low of $2.23. The 50-Day Moving Average of the stock is 8.71%, while the 200-Day Moving Average is calculated to be -11.88%.
Shares Statistics:
FDMT traded an average of 425.03K shares per day over the past three months and 476360 shares per day over the past ten days. A total of 46.32M shares are outstanding, with a floating share count of 41.55M. Insiders hold about 10.31% of the company’s shares, while institutions hold 88.42% stake in the company. Shares short for FDMT as of 1752537600 were 3619133 with a Short Ratio of 8.52, compared to 1749772800 on 4171819. Therefore, it implies a Short% of Shares Outstanding of 3619133 and a Short% of Float of 8.129999999999999.
